cta-logo01
  • News

    Most Read

    • AstraZeneca’s antibody reduces exacerbation rates in asthma trial
    • Medable to integrate Seqster technology in decentralised trial platform
    • Innovent doses first patient in US trial of advanced malignancy treatment

    Most Recent

    Clinical Trials

    AstraZeneca’s antibody reduces exacerbation rates in asthma trial

    01 Mar 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • OCT West Coast: how can decentralisation help optimise rare disease trials?
    • OCT West Coast: IQVIA’s Nagaraja Srivatsan talks decentralised trials and the future of clinical research
    • Neurology trends: Stroke leads Twitter mentions in Q4 2020

    Most Recent

    Clinical Trials

    OCT West Coast: how can decentralisation help optimise rare disease trials?

    26 Feb 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • AstraZeneca’s antibody reduces exacerbation rates in asthma trial
    • Cardiovascular trends: Imaging leads Twitter mentions in Q4 2020
    • Gastrointestinal trials and hematological disorders have highest proportion of studies disrupted by Covid-19

    Most Recent

    Clinical Trials

    AstraZeneca’s antibody reduces exacerbation rates in asthma trial

    01 Mar 2021
  • Themes
  • Deals

    Most Read

    • Altasciences completes acquisition of US-based CRO WCCT Global
    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink

    Most Recent

    Clinical Trials

    Altasciences completes acquisition of US-based CRO WCCT Global

    19 Feb 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Kolabtree
    • VaLea Clinical Trials
    • Linari NanoTech

    Most Recent

    Clinical Trials

    Kolabtree

    24 Feb 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

South and Central America accounts for 2.8% share of global clinical trial activity in 2020

26th February 2021

Middle East and Africa accounts for 11.2% share of global clinical trial activity in 2020

26th February 2021

Europe accounts for 19.3% share of global clinical trial activity in 2020

26th February 2021
OCT West Coast: how can decentralisation help optimise rare disease trials?

OCT West Coast: how can decentralisation help optimise rare disease trials?

Throughout the Covid-19 pandemic, decentralised clinical trials (DCTs) have been imperative for the continuation of...

26th February 2021
OCT West Coast: IQVIA’s Nagaraja Srivatsan talks decentralised trials and the future of clinical research

OCT West Coast: IQVIA’s Nagaraja Srivatsan talks decentralised trials and the future of clinical research

Decentralised clinical trials, and the digital technologies that facilitate them, have been a lifeline for...

25th February 2021
<b>Congestive Heart Failure accounts for 12.9% share of global Cardiovascular clinical trial activity in 2020</b>

Congestive Heart Failure accounts for 12.9% share of global Cardiovascular clinical trial activity in 2020

25th February 2021
<b>Coronary Artery Disease accounts for 12.5% share of global Cardiovascular clinical trial activity in 2020</b>

Coronary Artery Disease accounts for 12.5% share of global Cardiovascular clinical trial activity in 2020

25th February 2021
Hope remains that Roche’s prasinezumab can overcome recent string of failures in Parkinson’s disease

Hope remains that Roche’s prasinezumab can overcome recent string of failures in Parkinson’s disease

22nd February 2021
<b>North America accounts for 22.5% share of global clinical trial activity in 2020</b>

North America accounts for 22.5% share of global clinical trial activity in 2020

19th February 2021
Altasciences completes acquisition of US-based CRO WCCT Global

Altasciences completes acquisition of US-based CRO WCCT Global

Mid-size CRO/CDMO Altasciences has acquired early-stage clinical research organisation (CRO) WCCT Global.

19th February 2021

Latest News

Clinical Trials

AstraZeneca’s antibody reduces exacerbation rates in asthma trial

01 Mar 2021
Technology

Medable to integrate Seqster technology in decentralised trial platform

01 Mar 2021
Clinical Trials

Innovent doses first patient in US trial of advanced malignancy treatment

01 Mar 2021
Clinical Trials

Partner Therapeutics’ inhaled sargramostim improves lung function in trial

01 Mar 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more